Skip to main content

Acumen Pharmaceuticals, Inc.

ABOS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001576885

No open-market purchases or sales by Acumen Pharmaceuticals, Inc. insiders were filed in the last 90 days; 96 institutions reported holding it in 13F filings for Q2 2026, worth $127.8M in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in Acumen Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
52
+12 vs. Q3 2021
Shares held
25.6M
+1.69M (+7.1%) vs. Q3 2021
Total value
$172.9M
−$182.1M (−51.3%) vs. Q3 2021
New holders
13
23 more added
Sold out
1
6 more reduced

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ABOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 52 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 41 institutionsQ4 2021: 52 institutionsQ1 2022: 57 institutionsQ2 2022: 47 institutionsQ3 2022: 50 institutionsQ4 2022: 60 institutionsQ1 2023: 62 institutionsQ2 2023: 53 institutionsQ3 2023: 66 institutionsQ4 2023: 67 institutionsQ1 2024: 80 institutionsQ2 2024: 81 institutionsQ3 2024: 73 institutionsQ4 2024: 80 institutionsQ1 2025: 81 institutionsQ2 2025: 71 institutionsQ3 2025: 69 institutionsQ4 2025: 71 institutionsQ1 2026: 84 institutionsQ2 2026: 96 institutions
Value heldQ4 2021: $172.9M
Q1 2021: $0Q2 2021: $0Q3 2021: $357.4MQ4 2021: $172.9MQ1 2022: $106.1MQ2 2022: $120.5MQ3 2022: $278.4MQ4 2022: $158.0MQ1 2023: $114.0MQ2 2023: $126.6MQ3 2023: $181.4MQ4 2023: $147.8MQ1 2024: $176.3MQ2 2024: $105.5MQ3 2024: $107.8MQ4 2024: $73.2MQ1 2025: $44.8MQ2 2025: $43.6MQ3 2025: $61.1MQ4 2025: $75.2MQ1 2026: $108.5MQ2 2026: $127.8M
Institutions holding ABOS and their total value by quarter
QuarterHoldersValue
Q2 202696$127.8M
Q1 202684$108.5M
Q4 202571$75.2M
Q3 202569$61.1M
Q2 202571$43.6M
Q1 202581$44.8M
Q4 202480$73.2M
Q3 202473$107.8M
Q2 202481$105.5M
Q1 202480$176.3M
Q4 202367$147.8M
Q3 202366$181.4M
Q2 202353$126.6M
Q1 202362$114.0M
Q4 202260$158.0M
Q3 202250$278.4M
Q2 202247$120.5M
Q1 202257$106.1M
Q4 202152$172.9M
Q3 202141$357.4M
Q2 20210$0
Q1 20210$0

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Acumen Pharmaceuticals, Inc.; share changes are against Q3 2021.

Institutions holding ABOS in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Ra Capital Management, L.P.9,770,773$66.0M1.16%00.0%Unchanged
Sands Capital Ventures, LLC3,417,075$23.1M3.42%00.0%Unchanged
BlackRock Inc.3,109,670$21.0M0.00%+240,879+8.4%Added
Deep Track Capital, LP1,933,040$13.1M0.97%+1,933,040New
Rock Springs Capital Management LP1,571,918$10.6M0.25%−7,273−0.5%Reduced
Laurion Capital Management LP656,848$4.44M0.08%00.0%Unchanged
Janus Henderson Group PLC627,263$4.24M0.00%−232,918−27.1%Reduced
Franklin Resources Inc602,266$4.07M0.00%−335,234−35.8%Reduced
Vanguard Group Inc554,973$3.75M0.00%−769,925−58.1%Reduced
Guardian Point Capital, LP500,000$3.38M0.78%00.0%Unchanged
Woodline Partners LP480,681$3.25M0.05%+11,887+2.5%Added
Moore Capital Management, LP358,482$2.42M0.06%−11,101−3.0%Reduced
Goldman Sachs Group Inc323,264$2.19M0.00%+259,629+408.0%Added
BVF Inc289,663$1.96M0.07%00.0%Unchanged
Geode Capital Management, LLC171,879$1.16M0.00%+64,073+59.4%Added
Marshall Wace, LLP156,250$1.06M0.00%00.0%Unchanged
Pura Vida Investments, LLC126,060$852.0K0.09%+51,060+68.1%Added
State Street Corp111,363$753.0K0.00%+11,588+11.6%Added
Northern Trust Corp94,984$642.0K0.00%+7,583+8.7%Added
Schonfeld Strategic Advisors LLC86,543$585.0K0.01%+86,543New
HRT Financial LP81,917$553.0K0.00%+81,917New
Ergoteles LLC77,152$522.0K0.02%+77,152New
Citadel Advisors LLC74,523$504.0K0.00%+35,177+89.4%Added
Rex Capital Advisors, LLC65,336$442.0K0.23%+65,336New
Millennium Management LLC37,163$251.0K0.00%+37,163New
STRS Ohio33,300$225.0K0.00%+31,100+1,413.6%Added
D. E. Shaw & Co., Inc.27,167$184.0K0.00%+8,853+48.3%Added
Charles Schwab Investment Management Inc24,037$163.0K0.00%00.0%Unchanged
Renaissance Technologies LLC21,609$146.0K0.00%+21,609New
Bank of America Corp21,095$143.0K0.00%+20,105+2,030.8%Added
Morgan Stanley20,633$139.0K0.00%+20,064+3,526.2%Added
Jump Financial, LLC20,097$136.0K0.01%+20,097New
Bank of New York Mellon Corp19,180$129.0K0.00%+1,235+6.9%Added
Squarepoint Ops LLC18,818$127.0K0.00%+18,818New
Chicago Partners Investment Group LLC17,960$92.0K0.01%+3,156+21.3%Added
FMR LLC13,300$90.0K0.00%−93,800−87.6%Reduced
Nuveen Asset Management, LLC12,922$81.0K0.00%00.0%Unchanged
Cubist Systematic Strategies, LLC11,545$78.0K0.00%+11,545New
JPMorgan Chase & Co7,240$49.0K0.00%+3,568+97.2%Added
Tower Research Capital LLC (TRC)6,523$44.0K0.00%+5,828+838.6%Added
Deutsche Bank AG5,824$39.0K0.00%+306+5.5%Added
California State Teachers Retirement System5,659$38.0K0.00%+479+9.2%Added
New York State Common Retirement Fund5,481$37.0K0.00%+5,481New
American International Group, Inc.5,335$36.0K0.00%+88+1.7%Added
Citigroup Inc3,891$26.0K0.00%+2,797+255.7%Added
Royal Bank of Canada2,370$16.0K0.00%+1,269+115.3%Added
Wells Fargo & Company2,075$14.0K0.00%+2,024+3,968.6%Added
Legal & General Group Plc888$6.00K0.00%00.0%Unchanged
UBS Group AG857$6.00K0.00%+247+40.5%Added
Ameritas Investment Partners, Inc.735$5.00K0.00%00.0%Unchanged
Bedel Financial Consulting, Inc.240$2.00K0.00%+240New
FinTrust Capital Advisors, LLC20$00.00%+20New
Captrust Financial Advisors0$00.00%−78−100.0%Sold out
Marshall Wace North America L.P.––––Not filed